Cell lines formed from an individual's tumor can be used to predict response to specific therapies and determine genomic predictors. For mesothelioma, where chemotherapy remains the backbone of current therapeutic paradigms, such assays could be used to treat patients with the most effective agents specific to their "chemical profile." Clin Cancer Res; 24(7); 1513–5. ©2018 AACR.
See related article by Schunselaar et al., p. 1761
https://ift.tt/2JclVQk
Δεν υπάρχουν σχόλια:
Δημοσίευση σχολίου